Associate Professor UTHealth Houston McGovern Medical School UTHealth Houston McGovern Medical School, Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences , Texas
Despite tremendous health benefits, smoking cessation leads to an increased consumption of highly palatable foods. As a result, the majority of former smokers gain weight after quitting. Post-cessation weight gain (PCWG) can decrease smoking cessation motivation and success, and it can have detrimental effects on metabolic health in those who do achieve abstinence. This presentation will focus on the potential utility of glucagon-like peptide 1 receptor agonists (GLP1-RA) for addressing tobacco smoking and post-cessation weight management. The author will discuss the overall state of the science on targeting GLP-1Rs to reduce tobacco smoking and PCWG, with the primary focus on the completed and ongoing clinical trials conducted by our group. Directions for future clinical research will be provided.
Learning Objectives:
Learners will be able to:
Discuss the relationships between tobacco smoking, smoking cessation and body weight
Learn about the potential utility of GLP-1 receptor agonists for facilitating smoking abstinence and attenuating post-cessation weight gain
Discuss future directions for clinical research on GLP-1 receptor agonists in the context of smoking cessation
